Yang Tang,Li Yang,Wan Qin,Minxiao Yi,Bo Liu,Xianglin Yuan. A missense variant of MASP2 is associated with increased risk of radiation pneumonitis in lung cancer patients treated with radiation therapy. Oncol Transl Med, 2020, 6: 193-199.
A missense variant of MASP2 is associated with increased risk of radiation pneumonitis in lung cancer patients treated with radiation therapy
Received:May 07, 2020  Revised:September 01, 2020
View Full Text  View/Add Comment  Download reader
KeyWord:radiation pneumonitis; lung cancer; mannan-binding lectin-associated serine protease 2 (MASP2); Single Nucleotide Polymorphisms (SNP)
Author NameAffiliationE-mail
Yang Tang Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China tangyangtjmu@126.com 
Li Yang Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Wan Qin Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Minxiao Yi Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Bo Liu Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Xianglin Yuan Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Hits: 7354
Download times: 8284
Abstract:
      Objective In this study, mannan-binding lectin-associated serine protease 2 (MASP2) gene variant was evaluated to assess the risk of radiation pneumonitis (RP) in patients with pulmonary malignancies. Methods A total of 169 lung cancer patients with radiotherapy were included in our prospective study (NCT02490319) and genotyped using the Sanger sequencing method. Multivariate Cox hazards analysis and multiple testing were applied to estimate the hazard ratio (HR) and 95% confidence intervals (CIs) of all factors possibly associated with RP risk. Results?Patients?with?mean?lung?disease?≥?15?Gy?and?V 20 ?≥?24%?had?higher?risk?of?RP?≥?grade?2 compared with their counterparts (HR = 1.888, 95% CI: 1.186–3.004, P = 0.007; HR = 2.126, 95% CI: 1.338–3.378, P = 0.001, respectively). Importantly, CC + CA genotype of MASP2: rs12711521 was strongly associated?with?an?increased?occurrence?of?RP?≥?grade?2?(HR?=?1.949,?95%?CI:?1.278–2.971,?P = 0.002). Conclusion MASP2: rs12711521?was?found?to?be?significantly?associated?with?RP?≥?grade?2?in?our?cohort and may thus be one of the important predictors of severe RP before radiotherapy, if further validated in larger population.
Close